TLR5 and pneumococcal pneumonia: Previous studies demonstrated that i.n. administration of the TLR5 agonist flagellin, either by itself or during antibiotic-treated pneumococcal pneumonia, exerts immunostimulatory effects in the lung (9, 10, 22).